Centrex Limited Logo

Centrex Limited

CXM.AX

(1.2)
Stock Price

0,02 AUD

-29.79% ROA

-58.6% ROE

-1.86x PER

Market Cap.

33.784.374,00 AUD

13.36% DER

0% Yield

-42.05% NPM

Centrex Limited Stock Analysis

Centrex Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Centrex Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (26%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 PBV

The stock's PBV ratio (1.75x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

4 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-33.79%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-22.14%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-1) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Centrex Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Centrex Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Centrex Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Centrex Limited Revenue
Year Revenue Growth
2005 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 43.000 100%
2020 0 0%
2020 0 0%
2021 0 0%
2022 214.000 100%
2023 25.967.000 99.18%
2024 57.060.000 54.49%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Centrex Limited Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Centrex Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2007 1.147.299 100%
2008 1.584.845 27.61%
2009 2.167.202 26.87%
2010 1.922.859 -12.71%
2011 2.047.707 6.1%
2012 2.484.240 17.57%
2013 2.840.940 12.56%
2014 2.482.562 -14.44%
2015 1.803.695 -37.64%
2016 1.308.458 -37.85%
2017 1.180.537 -10.84%
2018 1.399.877 15.67%
2019 1.842.000 24%
2020 1.135.000 -62.29%
2020 1.135.000 0%
2021 621.000 -82.77%
2022 2.037.000 69.51%
2023 7.304.000 72.11%
2024 15.652.000 53.34%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Centrex Limited EBITDA
Year EBITDA Growth
2005 0
2007 -726.853 100%
2008 -1.858.254 60.89%
2009 -3.717.648 50.02%
2010 -5.103.206 27.15%
2011 69.222.986 107.37%
2012 977.264 -6983.35%
2013 1.552.672 37.06%
2014 -3.087.102 150.3%
2015 -16.605.660 81.41%
2016 -1.615.060 -928.18%
2017 -1.436.760 -12.41%
2018 -1.603.030 10.37%
2019 -2.267.000 29.29%
2020 -19.805.000 88.55%
2020 -1.395.000 -1319.71%
2021 -861.000 -62.02%
2022 -2.327.000 63%
2023 -8.457.000 72.48%
2024 -29.628.000 71.46%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Centrex Limited Gross Profit
Year Gross Profit Growth
2005 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 -104.809 100%
2015 0 0%
2016 -131.324 100%
2017 -32.299 -306.59%
2018 -13.077 -146.99%
2019 23.000 156.86%
2020 0 0%
2020 -14.000 100%
2021 -12.000 -16.67%
2022 -1.247.000 99.04%
2023 -1.746.000 28.58%
2024 -13.764.000 87.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Centrex Limited Net Profit
Year Net Profit Growth
2005 0
2007 -657.013 100%
2008 -1.246.394 47.29%
2009 -2.181.115 42.86%
2010 -1.837.302 -18.71%
2011 47.528.580 103.87%
2012 673.476 -6957.2%
2013 1.004.564 32.96%
2014 -734.552 236.76%
2015 -14.821.127 95.04%
2016 -4.987.053 -197.19%
2017 488.828 1120.21%
2018 -1.139.938 142.88%
2019 -1.384.000 17.63%
2020 -19.821.000 93.02%
2020 -19.821.000 0%
2021 -2.627.000 -654.51%
2022 -21.655.000 87.87%
2023 -9.548.000 -126.8%
2024 -32.863.996 70.95%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Centrex Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Centrex Limited Free Cashflow
Year Free Cashflow Growth
2007 -2.517.392
2008 -5.098.861 50.63%
2009 -11.320.926 54.96%
2010 -234.774 -4722.05%
2011 -8.092.934 97.1%
2012 -2.330.392 -247.28%
2013 -6.308.903 63.06%
2014 -5.060.531 -24.67%
2015 -8.849.503 42.82%
2016 -4.312.914 -105.19%
2017 -7.800.115 44.71%
2018 -6.273.000 -24.34%
2019 -10.330.999 39.28%
2020 -3.505.000 -194.75%
2020 -326.250 -974.33%
2021 -1.632.000 80.01%
2022 -9.217.000 82.29%
2023 -9.411.000 2.06%
2024 -5.105.000 -84.35%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Centrex Limited Operating Cashflow
Year Operating Cashflow Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 -3.915.427 100%
2014 -2.324.623 -68.43%
2015 -2.942.419 21%
2016 -1.678.233 -75.33%
2017 -288.236 -482.24%
2018 -633.000 54.47%
2019 -2.057.999 69.24%
2020 -2.200.000 6.45%
2020 0 0%
2021 -915.000 100%
2022 -1.570.000 41.72%
2023 -6.962.000 77.45%
2024 -2.804.000 -148.29%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Centrex Limited Capital Expenditure
Year Capital Expenditure Growth
2007 2.517.392
2008 5.098.861 50.63%
2009 11.320.926 54.96%
2010 234.774 -4722.05%
2011 8.092.934 97.1%
2012 2.330.392 -247.28%
2013 2.393.476 2.64%
2014 2.735.908 12.52%
2015 5.907.084 53.68%
2016 2.634.681 -124.2%
2017 7.511.879 64.93%
2018 5.640.000 -33.19%
2019 8.273.000 31.83%
2020 1.305.000 -533.95%
2020 326.250 -300%
2021 717.000 54.5%
2022 7.647.000 90.62%
2023 2.449.000 -212.25%
2024 2.301.000 -6.43%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Centrex Limited Equity
Year Equity Growth
2005 9.473.140
2007 10.963.457 13.59%
2008 27.153.802 59.62%
2009 27.074.644 -0.29%
2010 34.959.920 22.56%
2011 83.638.169 58.2%
2012 84.520.185 1.04%
2013 70.171.298 -20.45%
2014 53.988.490 -29.97%
2015 39.219.001 -37.66%
2016 34.263.223 -14.46%
2017 34.752.051 1.41%
2018 33.651.000 -3.27%
2019 32.412.000 -3.82%
2020 12.699.000 -155.23%
2021 11.285.000 -12.53%
2022 31.696.000 64.4%
2023 24.825.000 -27.68%
2024 21.767.000 -14.05%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Centrex Limited Assets
Year Assets Growth
2005 10.121.916
2007 11.335.322 10.7%
2008 27.949.053 59.44%
2009 27.669.523 -1.01%
2010 37.100.360 25.42%
2011 108.150.462 65.7%
2012 90.154.746 -19.96%
2013 76.059.363 -18.53%
2014 59.880.445 -27.02%
2015 39.900.342 -50.08%
2016 34.955.588 -14.15%
2017 35.516.867 1.58%
2018 34.958.000 -1.6%
2019 33.579.000 -4.11%
2020 13.010.000 -158.1%
2021 14.691.000 11.44%
2022 36.372.000 59.61%
2023 43.133.000 15.67%
2024 45.834.000 5.89%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Centrex Limited Liabilities
Year Liabilities Growth
2005 648.776
2007 371.865 -74.47%
2008 795.251 53.24%
2009 594.879 -33.68%
2010 2.140.440 72.21%
2011 24.512.293 91.27%
2012 5.634.561 -335.03%
2013 5.888.065 4.31%
2014 5.891.955 0.07%
2015 681.341 -764.76%
2016 692.365 1.59%
2017 764.816 9.47%
2018 1.307.000 41.48%
2019 1.167.000 -12%
2020 312.000 -274.04%
2021 3.406.000 90.84%
2022 4.676.000 27.16%
2023 18.308.000 74.46%
2024 24.067.000 23.93%

Centrex Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.05
Net Income per Share
-0.02
Price to Earning Ratio
-1.86x
Price To Sales Ratio
1.04x
POCF Ratio
-8.62
PFCF Ratio
-5.07
Price to Book Ratio
1.17
EV to Sales
1.04
EV Over EBITDA
-2.79
EV to Operating CashFlow
-11.41
EV to FreeCashFlow
-5.05
Earnings Yield
-0.54
FreeCashFlow Yield
-0.2
Market Cap
0,03 Bil.
Enterprise Value
0,03 Bil.
Graham Number
0.13
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
0.22
ROE
-0.59
Return On Assets
-0.3
Return On Capital Employed
-0.49
Net Income per EBT
1
EBT Per Ebit
1.08
Ebit per Revenue
-0.39
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0.35
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
-0.18
Operating Profit Margin
-0.39
Pretax Profit Margin
-0.42
Net Profit Margin
-0.42

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-1.26
Capex to Revenue
0.11
Capex to Depreciation
3.05
Return on Invested Capital
-0.51
Return on Tangible Assets
-0.3
Days Sales Outstanding
1.17
Days Payables Outstanding
108.81
Days of Inventory on Hand
60.09
Receivables Turnover
312.19
Payables Turnover
3.35
Inventory Turnover
6.07
Capex per Share
0.01

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,03
Tangible Book Value per Share
0.03
Shareholders Equity per Share
0.03
Interest Debt per Share
0.01
Debt to Equity
0.13
Debt to Assets
0.06
Net Debt to EBITDA
0.01
Current Ratio
0.52
Tangible Asset Value
0,02 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
24827000
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,01 Bil.
Average Inventory
5509000
Debt to Market Cap
0.09

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Centrex Limited Dividends
Year Dividends Growth
2013 0
2014 0 0%

Centrex Limited Profile

About Centrex Limited

Centrex Limited operates as a mineral exploration company in Australia. The company explores for phosphate, potash, zinc, lead, gold, and copper deposits. Its flagship project is the Ardmore phosphate rock project located to the south of Mount Isa in North West Queensland. It holds 100% interests in the Oxley Potash Project in the Midwest of Western Australia; and the Goulburn base metals project located in the Lachlan Fold Belt, New South Wales. The company was formerly known as Centrex Metals Limited and changed its name to Centrex Limited in December 2021. Centrex Limited was incorporated in 2001 and is based in Adelaide, Australia.

CEO
Mr. Robert John Mencel
Employee
11
Address
44 Waymouth Street
Adelaide, 5000

Centrex Limited Executives & BODs

Centrex Limited Executives & BODs
# Name Age
1 Mr. Brian Hall
General Manager of Ardmore Rock Phosphate Mine
70
2 Mr. Robert John Mencel
Chief Executive Officer, MD & Executive Director
70
3 Mr. Cormac Byrne
Chief Financial Officer
70
4 Mr. Enzo Artone
Chief Technical Officer
70
5 Ms. Hiti Taluja
Chief Commercial Officer
70
6 Mr. Alastair Watts B.Sc., BSc (Geol), Dip Bus, MAusIMM
General Manager of Exploration
70
7 Dr. John Reginald Santich B.E., DipLaw, MEngSc, MSocSc., Ph.D.
Company Secretary
70

Centrex Limited Competitors

Avenira Limited Logo
Avenira Limited

AEV.AX

(1.0)
CZR Resources Ltd Logo
CZR Resources Ltd

CZR.AX

(0.5)
Fertoz Limited Logo
Fertoz Limited

FTZ.AX

(1.5)